HARARE – Zimbabwe is one of the seven African countries where clinical trials for a long-lasting injectable antiretroviral drug developed in Uganda would be conducted. Uganda, which has already started recruiting women for trials for the injectable drug for Pre-Exposure Prophylaxis, is taking the lead with Zimbabwe joining Kenya, Malawi, Botswana, Zimbabwe, South Africa and…
To access this content, please purchase a subscription by clicking the button below and select a package of your choice!
Subscriptions